93.077: Family Smoking Prevention and Tobacco Control Act Regulatory Research

93.077

Active

National Institutes of Health (NIH) [HHS]

Aug. 5, 2022

Aug. 5, 2022

The Family Smoking Prevention and Tobacco Control Act (TCA) provides the authority to regulate tobacco product manufacturing, distribution and marketing. Regulatory research will provide the scientific evidence to guide the implementation of this authority. Research areas include: 1) approaches that test the toxicity of tobacco smoke, aerosol, or specific constituents, 2) the effect of tobacco product characteristics on addiction and abuse liability, 3) the short and long term health effects of tobacco products, 4) understanding the knowledge, attitudes and behaviors related to tobacco product use, 5) understanding how to effectively communicate the health effects of tobacco products, 6) the influences of tobacco marketing, and 7) understanding the impact of potential FDA regulatory actions. The strategic priorities for these research areas can be found at https://www.fda.gov/tobacco-products/research/research-priorities

B - Project Grants

Applicants should review the eligibility information in the individual funding opportunity announcements issued under this CFDA.

This Tobacco Control Regulatory Research Program will support research aimed at providing guidance and evidence to develop regulation for tobacco product manufacturing, distribution and marketing. The general public will ultimately benefit.

https://sam.gov/fal/be82b2e511b744ad95f9374ffde6a388/view